Cabaletta Bio (CABA) Short Interest Ratio & Short Volume $1.32 +0.04 (+3.13%) As of 04/30/2025 04:00 PM Eastern Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Cabaletta Bio Short Interest DataCabaletta Bio (CABA) has a short interest of 5.80 million shares, representing 13.17% of the float (the number of shares available for trading by the public). This marks a -5.38% decrease in short interest from the previous month. The short interest ratio (days to cover) is 5.5, indicating that it would take 5.5 days of the average trading volume of 1.45 million shares to cover all short positions.Current Short Interest5,800,000 sharesPrevious Short Interest6,130,000 sharesChange Vs. Previous Month-5.38%Dollar Volume Sold Short$6.50 millionShort Interest Ratio5.5 Days to CoverLast Record DateApril 15, 2025Outstanding Shares50,743,000 sharesShort Percent of Float13.17%Today's Trading Volume467,490 sharesAverage Trading Volume1,449,779 sharesToday's Volume Vs. Average32% Short Selling Cabaletta Bio? Sign up to receive the latest short interest report for Cabaletta Bio and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCABA Short Interest Over TimeCABA Days to Cover Over TimeCABA Percentage of Float Shorted Over Time Cabaletta Bio Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20255,800,000 shares $6.50 million -5.4%13.2%5.5 $1.12 3/31/20256,130,000 shares $8.49 million -1.6%13.9%5.1 $1.39 3/15/20256,230,000 shares $11.34 million -7.8%14.1%5 $1.82 2/28/20256,760,000 shares $12.20 million +9.0%15.3%4.5 $1.81 2/15/20256,200,000 shares $16.80 million -0.8%14.1%2.5 $2.71 1/31/20256,250,000 shares $14.94 million -3.1%N/A2.5 $2.39 1/15/20256,450,000 shares $14.32 million +7.1%N/A2.6 $2.22 12/31/20246,020,000 shares $13.67 million -3.2%N/A2.5 $2.27 12/15/20246,220,000 shares $17.54 million +38.2%N/A2.7 $2.82 11/30/20244,500,000 shares $17.19 million +25.0%N/A2 $3.82 Get the Latest News and Ratings for CABA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cabaletta Bio and its competitors with MarketBeat's FREE daily newsletter. 11/15/20243,600,000 shares $10.91 million -3.0%N/A2.8 $3.03 10/31/20243,710,000 shares $13.17 million -1.9%N/A4 $3.55 10/15/20243,780,000 shares $16.37 million -29.0%N/A3.6 $4.33 9/30/20245,320,000 shares $25.11 million -16.7%N/A5.1 $4.72 9/15/20246,390,000 shares $26.26 million No ChangeN/A5.7 $4.11 8/31/20246,390,000 shares $35.98 million +1.8%N/A5.1 $5.63 8/15/20246,280,000 shares $28.01 million -28.4%N/A4.8 $4.46 7/31/20248,770,000 shares $62.27 million +16.8%N/A7.1 $7.10 7/15/20247,510,000 shares $58.65 million +4.6%N/A5.7 $7.81 6/30/20247,180,000 shares $53.71 million -24.0%N/A5.4 $7.48 6/15/20249,450,000 shares $100.74 million -0.2%N/A7.2 $10.66 5/31/20249,470,000 shares $96.50 million +4.1%N/A8.1 $10.19 5/15/20249,100,000 shares $115.48 million -11.2%N/A8.1 $12.69 4/30/202410,250,000 shares $109.11 million +3.9%N/A8.9 $10.65 4/15/20249,870,000 shares $159.70 million +16.1%N/A10.3 $16.18 3/31/20248,500,000 shares $145.01 million +19.9%N/A9 $17.06 3/15/20247,090,000 shares $132.87 million +1.1%N/A7.9 $18.74 2/29/20247,010,000 shares $160.39 million +2.6%N/A7.1 $22.88 2/15/20246,830,000 shares $163.24 million +6.9%N/A5.4 $23.90 1/31/20246,390,000 shares $130.87 million -0.5%N/A5 $20.48 1/15/20246,420,000 shares $136.10 million +3.2%N/A5.4 $21.20 12/31/20236,220,000 shares $141.19 million +10.5%N/A5.3 $22.70 12/15/20235,630,000 shares $115.70 million -0.7%N/A4.8 $20.55 11/30/20235,670,000 shares $91.00 million +12.1%N/A4.9 $16.05 11/15/20235,060,000 shares $87.89 million -19.4%N/A6.4 $17.37 10/31/20236,280,000 shares $89.55 million +1.5%N/A8.6 $14.26 10/15/20236,190,000 shares $94.83 million +19.3%N/A9.1 $15.32 9/30/20235,190,000 shares $78.99 million +65.3%N/A8 $15.22 9/15/20233,140,000 shares $49.64 million -3.7%N/A5 $15.81 8/31/20233,260,000 shares $46.16 million -39.2%N/A6 $14.16The Man I Turn to In Times Like This (Ad)A storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when publisher Brett Aitken turns to Whitney Tilson—a man CNBC once dubbed “The Prophet.” Tilson just released a new prediction that runs counter to what mainstream finance is telling you.Market chaos? Hear Tilson’s take now 8/15/20235,360,000 shares $73.27 million +6.1%N/A11.6 $13.67 7/31/20235,050,000 shares $68.78 million -8.4%N/A10.4 $13.62 7/15/20235,510,000 shares $66.73 million +4.8%N/A11 $12.11 6/30/20235,260,000 shares $67.91 million +22.3%N/A11.2 $12.91 6/15/20234,300,000 shares $55.34 million +7.0%N/A9.9 $12.87 5/31/20234,020,000 shares $40.56 million +1.0%N/A11.8 $10.09 5/15/20233,980,000 shares $45.69 million -0.5%N/A11 $11.48 4/30/20234,000,000 shares $41.52 million -1.0%N/A10.3 $10.38 4/15/20234,040,000 shares $31.55 million +9.8%N/A9.3 $7.81 3/31/20233,680,000 shares $30.43 million +3.1%N/A7.2 $8.27 3/15/20233,570,000 shares $26.45 million +2.6%N/A5.5 $7.41 2/28/20233,480,000 shares $30.76 million +3.0%N/A4.6 $8.84 2/15/20233,380,000 shares $27.21 million -0.3%N/A4.2 $8.05 1/31/20233,390,000 shares $41.32 million +3.7%N/A3.9 $12.19 1/15/20233,270,000 shares $32.77 million -7.4%N/A2.6 $10.02 12/30/20223,530,000 shares $32.65 million -0.3%N/A2.6 $9.25 12/15/20223,540,000 shares $23.90 million -3.5%N/A2.7 $6.75 11/30/20223,670,000 shares $16.44 million +6.4%N/A2.8 $4.48 11/15/20223,450,000 shares $12.32 million -8.5%N/A2.3 $3.57 10/31/20223,770,000 shares $6.37 million +5.9%N/A1.9 $1.69 10/15/20223,560,000 shares $3.03 million -23.6%N/A1.8 $0.85 9/30/20224,660,000 shares $3.03 million +11.8%N/A3.5 $0.65 9/15/20224,170,000 shares $3.67 million +21.2%N/A3.2 $0.88 8/31/20223,440,000 shares $3.28 million +55.0%N/A2.8 $0.95 8/15/20222,220,000 shares $3.40 million +8.3%N/A2.4 $1.53 7/31/20222,050,000 shares $2.42 million +4.6%N/A11.3 $1.18 7/15/20221,960,000 shares $3.04 million +6.5%N/A12.2 $1.55 6/30/20221,840,000 shares $1.95 million +0.6%N/A11.4 $1.06 6/15/20221,830,000 shares $1.83 million +1.7%N/A12.2 $1.00 5/31/20221,800,000 shares $2.30 million -1.6%N/A11.2 $1.28 5/15/20221,830,000 shares $2.73 million +2.8%N/A10.3 $1.49 4/30/20221,780,000 shares $2.46 million No ChangeN/A10.1 $1.38 4/15/20221,780,000 shares $3.24 million -2.2%N/A10 $1.82 3/31/20221,820,000 shares $3.69 million No ChangeN/A11 $2.03 3/15/20221,820,000 shares $3.06 million +2.8%N/A8.7 $1.68 2/28/20221,770,000 shares $3.82 million No ChangeN/A3 $2.16 2/15/20221,770,000 shares $5.01 million -0.6%N/A3.1 $2.83 1/31/20221,780,000 shares $5.38 million -1.1%N/A3 $3.02 1/15/20221,800,000 shares $6.17 million -1.1%N/A3 $3.43 12/31/20211,820,000 shares $6.90 million -1.1%N/A3 $3.79 12/15/20211,840,000 shares $7.30 million +1.1%N/A3.1 $3.97 11/30/20211,820,000 shares $21.08 million +10.3%N/A11.1 $11.58 11/15/20211,650,000 shares $19.93 million +22.2%N/A8.1 $12.08 10/29/20211,350,000 shares $18.45 million No ChangeN/A7 $13.67 10/15/20211,350,000 shares $16.55 million No Change8.7%8 $12.26 9/30/20211,350,000 shares $16.42 million +0.8%8.7%9.1 $12.16 9/15/20211,340,000 shares $15.54 million +1.5%8.7%8.2 $11.60 8/31/20211,320,000 shares $13.44 million +0.8%8.9%8.2 $10.18 8/13/20211,310,000 shares $9.77 million -1.5%8.8%11.2 $7.46 7/30/20211,330,000 shares $9.92 million -1.5%8.4%11.4 $7.46The Man I Turn to In Times Like This (Ad)A storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when publisher Brett Aitken turns to Whitney Tilson—a man CNBC once dubbed “The Prophet.” Tilson just released a new prediction that runs counter to what mainstream finance is telling you.Market chaos? Hear Tilson’s take now 7/15/20211,350,000 shares $10.14 million -1.5%8.5%10.5 $7.51 6/30/20211,370,000 shares $11.78 million -11.6%8.7%10 $8.60 6/15/20211,550,000 shares $12.21 million +1.3%9.8%14.3 $7.88 5/28/20211,530,000 shares $17.35 million -6.1%9.7%15.1 $11.34 5/14/20211,630,000 shares $14.31 million -4.7%12.0%14.9 $8.78 4/30/20211,710,000 shares $19.49 million +1.2%10.4%15.6 $11.40 4/15/20211,690,000 shares $19.01 million -2.9%9.5%15.5 $11.25 3/31/20211,740,000 shares $18.32 million +1.2%9.8%15.9 $10.53 3/15/20211,720,000 shares $20.49 million +5.5%9.7%14.3 $11.91 2/26/20211,630,000 shares $18.17 million +1.2%9.2%13.5 $11.15 2/12/20211,610,000 shares $20.13 million +4.6%9.1%14.9 $12.50 1/29/20211,540,000 shares $19.33 million +4.8%8.7%15.2 $12.55 1/15/20211,470,000 shares $20.02 million +2.8%8.3%15.2 $13.62 12/31/20201,430,000 shares $17.52 million +5.2%8.3%15.9 $12.25 12/15/20201,360,000 shares $20.20 million +4.6%7.8%17.7 $14.85 11/30/20201,300,000 shares $19.54 million +7.4%7.6%18.4 $15.03 11/15/20201,210,000 shares $16.95 million +0.8%7.1%16.4 $14.01 10/30/20201,200,000 shares $14.66 million +2.6%7.1%16 $12.22 10/15/20201,170,000 shares $12.83 million +7.3%6.9%14.2 $10.97 9/30/20201,090,000 shares $11.82 million +11.0%6.4%11.4 $10.84 9/15/2020981,800 shares $11.39 million +4.5%5.8%6.1 $11.60 8/31/2020939,400 shares $9.91 million +4.0%5.5%6.1 $10.55 8/14/2020903,300 shares $10.30 million -21.5%5.3%5.6 $11.40 7/31/20201,150,000 shares $13.14 million +26.6%6.8%6.9 $11.43 7/15/2020908,200 shares $9.96 million -26.8%7.3%5.3 $10.97 6/30/20201,240,000 shares $13.81 million +348.8%9.9%7.6 $11.14 6/15/2020276,300 shares $2.16 million +132.0%2.2%2.8 $7.81 5/29/2020119,100 shares $990,912.00 +21.7%1.0%1.2 $8.32 5/15/202097,900 shares $690,195.00 -19.0%0.8%1.2 $7.05 CABA Short Interest - Frequently Asked Questions What is Cabaletta Bio's current short interest? Short interest is the volume of Cabaletta Bio shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 5,800,000 shares of CABA short. 13.17% of Cabaletta Bio's shares are currently sold short. Learn More on Cabaletta Bio's current short interest. What is a good short interest ratio for Cabaletta Bio? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CABA shares currently have a short interest ratio of 6.0. Learn More on Cabaletta Bio's short interest ratio. Which institutional investors are shorting Cabaletta Bio? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Cabaletta Bio: Group One Trading LLC, Citadel Advisors LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Cabaletta Bio? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 13.17% of Cabaletta Bio's floating shares are currently sold short. Is Cabaletta Bio's short interest increasing or decreasing? Cabaletta Bio saw a decrease in short interest during the month of April. As of April 15th, there was short interest totaling 5,800,000 shares, a decrease of 5.4% from the previous total of 6,130,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Cabaletta Bio's short interest compare to its competitors? 13.17% of Cabaletta Bio's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Cabaletta Bio: Aurora Cannabis Inc. (9.05%), Bright Minds Biosciences Inc. (1.77%), Astria Therapeutics, Inc. (6.79%), Acelyrin, Inc. (5.04%), Humacyte, Inc. (20.75%), Lifecore Biomedical, Inc. (7.75%), Solid Biosciences Inc. (12.52%), Immutep Limited (2.93%), Cidara Therapeutics, Inc. (7.04%), Foghorn Therapeutics Inc. (3.84%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.71 billion), iShares 20+ Year Treasury Bond ETF ($9.48 billion), Strategy Incorporated ($8.92 billion), Charter Communications, Inc. ($3.86 billion), Apollo Global Management, Inc. ($3.86 billion), Capital One Financial Co. ($3.72 billion), Super Micro Computer, Inc. ($3.47 billion), AppLovin Co. ($2.64 billion), VanEck Semiconductor ETF ($2.46 billion), and The Kroger Co. ($2.33 billion). View all of the most shorted stocks. What does it mean to sell short Cabaletta Bio stock? Short selling CABA is an investing strategy that aims to generate trading profit from Cabaletta Bio as its price is falling. CABA shares are trading up $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Cabaletta Bio? A short squeeze for Cabaletta Bio occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CABA, which in turn drives the price of the stock up even further. How often is Cabaletta Bio's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CABA, twice per month. The most recent reporting period available is April, 15 2025. More Short Interest Resources from MarketBeat Related Companies Aurora Cannabis Short Interest Data Bright Minds Biosciences Short Interest Data Astria Therapeutics Short Interest Data Acelyrin Short Interest Data Humacyte Short Interest Data Lifecore Biomedical Short Interest Data Solid Biosciences Short Interest Data Immutep Short Interest Data Cidara Therapeutics Short Interest Data Foghorn Therapeutics Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CABA) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredThey rigged the gameThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredIf you missed your chance with Tesla...Elon Musk is moments from launching a revolutionary technology some Silicon Valley insiders are calling "The F...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cabaletta Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cabaletta Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
